By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Vitamin D Takes Center Stage in Brain Dopamine Regulation, Offering New Parkinson’s Prevention Insights

Vitamin D Takes Center Stage in Brain Dopamine Regulation, Offering New Parkinson’s Prevention Insights

GMJ
Last updated: 03/06/2026 16:55
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Brain neurons with vitamin D receptors controlling dopamine production
New research reveals vitamin D receptors are physically present in dopamine-producing brain neurons, where they directly control neurotransmitter synthesis and neuronal survival. Studies show activation can double dopamine cell production, with implications for Parkinson's disease prevention. — Photo: cottonbro studio / Pexels
SHARE
1 min read|127 words

Vitamin D’s role in human health extends far beyond calcium absorption and bone strength. Recent neuroscience research reveals that vitamin D directly regulates dopamine production within the brain’s substantia nigra—the critical region that degenerates in Parkinson’s disease patients.

Studies by Cui and colleagues demonstrate that vitamin D receptors are physically embedded within dopamine-producing neurons, where they control three essential genes governing both dopamine synthesis and neuronal survival. When vitamin D activates these neural receptors, the effects are substantial and measurable. Research published in Neuroscience showed that vitamin D treatment can increase tyrosine hydroxylase expression—the rate-limiting enzyme in dopamine production—effectively doubling the capacity of dopamine-producing cells.

This discovery opens promising avenues for understanding how nutritional factors influence neurodegenerative disease development and potentially inform preventive strategies.

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: Vitamin D Directly Controls Dopamine Production in Human Brain Neurons According to Cui et al. Research →

Related reference
  • Vitamin D · Ingredient
  • Calcium · Ingredient
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Global Atopic Dermatitis Burden Exceeds 400 Million Cases: Nature Reviews Updates Landmark Evidence

An updated analysis in Nature Reviews Disease Primers (June 2026) confirms atopic…

Myanmar’s Digital Divide Deepens as Conflict Intensifies: Unequal Internet Access Correlates With Worsening Social Isolation

A longitudinal analysis across Myanmar reveals profound digital inequalities that track with…

Why Food Labels Alone Won’t Stop Child Obesity in Latin America—Evidence From Ecuador

Latin American countries have implemented front-of-package warning labels and advertising restrictions, yet…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Medical illustration showing targeted cancer therapy mechanism

Two Decades Without Progress: NHS Finally Approves Next-Generation Ovarian Cancer Treatment

By
Prof. Giorgi Pkhakadze
01/07/2026
Diagram of insulin receptor signalling pathway highlighting magnesium's role as essential cofactor in kinase activation

Announcement: Magnesium’s Hidden Role in Insulin Signalling: Why the Mineral Matters More Than We Thought

By
Prof. Giorgi Pkhakadze
26/07/2026
Global HealthPolicy & Systems

WHO Declares International Emergency as Ebola Outbreak Spreads from Congo to Uganda

By
Prof. Giorgi Pkhakadze
31/05/2026
Medical chart showing STI prevalence rates among HIV-positive patients in China

China’s Largest HIV Study Uncovers Critical Care Gaps: 40% Face Recurrent STI Infections

By
Prof. Giorgi Pkhakadze
31/05/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up